Enrique Rivas

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

Medicine, Dermatology, Immunology +14

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

Luis Villar, Gustavo H. Dayan, José Luis Arredondo-Garcı́a et al. · New England Journal of Medicine · 2014 · 942 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomized, controlled trial

Christine Bodemer, Andrzej Kaszuba, Külli Kingo et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 94 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Guy de Bruyn, David Gordon, Theodore S. Steiner et al. · The Lancet Infectious Diseases · 2020 · 77 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds

Luis Villar, Doris Maribel Rivera-Medina, José Luis Arredondo-Garcı́a et al. · The Pediatric Infectious Disease Journal · 2013 · 72 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17